Cetuximab-IRDye 800CW
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cetuximab-IRDye 800CW, covering 2018-05-14 to 2019-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery [Phase 2]